A Single-Arm Pre-Post Study

NCT07765290 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-08-14

No results posted yet for this study

Summary

This interventional single-arm pre-post study aimed to investigate the acute effects of repeated Wingate exercise on free thyroid hormone responses in male amateur soccer players. Twenty healthy male amateur soccer players aged 19-22 years completed a standardized repeated Wingate exercise protocol. Blood samples were collected immediately before and after exercise to determine serum free triiodothyronine (fT3), free thyroxine (fT4), and thyroid-stimulating hormone (TSH) concentrations. The study evaluated the immediate endocrine responses to repeated high-intensity anaerobic exercise and their potential implications for exercise physiology and thyroid hormone regulation.

Conditions

  • Exercise Physiology

Interventions

BEHAVIORAL

Repeated Wingate Exercise

Participants completed a standardized repeated Wingate exercise protocol under controlled laboratory conditions to investigate the acute effects of high-intensity anaerobic exercise on thyroid hormone responses. Venous blood samples were collected immediately before and immediately after the exercise session to measure serum free triiodothyronine (fT3), free thyroxine (fT4), and thyroid-stimulating hormone (TSH) concentrations.

Sponsors & Collaborators

  • İnönü University

    collaborator UNKNOWN
  • Inonu University

    lead OTHER

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Max Age
22 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-15
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07765290 on ClinicalTrials.gov